Marijuana is prescribed to help ease chronic pain and control nausea in cancer patients, but legal red tape has made more comprehensive research difficult.

The marijuana industry has sold us a bill of goods, and we’ve given ourselves over to a mass mania, disregarding scientific proof.

The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.

A recent review published in JAMA found that the evidence to support the use of cannabis and cannabinoids for most medical indications is insufficient. The authors state that only specific pharmaceutical-grade cannabinoid products approved by the Food and Drug Administration (FDA) have demonstrated clear clinical benefits.

The U.S. Department of Transportation (DOT) is advising that all safety-sensitive workers must still comply with federal drug testing requirements, even as the president directs the attorney general to complete a cannabis rescheduling process.

By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1.  Purpose and

New research reveals significant gaps between public perception and scientific evidence for medical cannabis benefits across most health conditions.

Ohioans for Cannabis Choice faces a 90-day deadline to collect roughly 250,000 signatures from across the state to block Senate Bill 56 signed by Gov. DeWine last week.

Teen marijuana use “remained stable” this year even as more states have enacted legalization, according to an annual federally funded survey The Monitoring the Future (MTF) survey—supported by the National Institute on Drug Abuse (NIDA) and conducted every year for decades by the University of Michigan—examines substance use trends among 8th,

The co-presenters, in coordination with Premier Graphene Inc. and HGI Industrial Technologies, uniquely position BIEI for success. MEXICO CITY, (GLOBE NEWSWIRE) -- P